{
    "id": "0696",
    "question": "A 38-year-old woman presents to her primary care physician for her yearly exam. Her only complaint is difficulty losing weight. Her BMI is 34 kg/m^2. In addition to a standard physical exam, the physician orders a glucose tolerance test. The woman's fasting blood glucose level is 120 mg/dL and two-hour post 75g glucose load blood glucose level is 190 mg/dL. The physician informs the patient that she is \"pre-diabetic\" or at risk of developing diabetes and recommends lifestyle modification with follow-up in 6 months. Which of the following endogenous signaling molecules or receptors will increase insulin sensitivity in this patient?",
    "options": {
        "A": "Catecholamines",
        "B": "Glucagon",
        "C": "Glucocorticoids",
        "D": "Peroxisome proliferator-activated receptor gamma"
    },
    "answer": "D",
    "predict": "To approach this question, let's break down the key points: 1. The patient is presenting with difficulty losing weight and has a BMI of 34 kg/m^2, indicating obesity, which is a risk factor for developing insulin resistance and type 2 diabetes. 2. The glucose tolerance test results show that the patient's fasting blood glucose level is 120 mg/dL and two-hour post 75g glucose load blood glucose level is 190 mg/dL, indicating impaired glucose regulation and a pre-diabetic state. 3. The physician recommends lifestyle modification and follow-up in 6 months, indicating a focus on improving insulin sensitivity. Now, let's analyze the options: A. Catecholamines: These are hormones produced by the adrenal glands that increase glucose release from storage sites (glycogenolysis and gluconeogenesis) and increase glucose uptake in the liver, but they do not increase insulin sensitivity. B. Glucagon: This hormone, produced by the pancreas, raises blood glucose levels by stimulating glycogenolysis and gluconeogenesis, which is the opposite of increasing insulin sensitivity. C. Glucocorticoids: These hormones, produced by the adrenal glands, have a complex role in glucose metabolism. While they can increase glucose uptake in the liver, they also promote gluconeogenesis and lipolysis, which can worsen insulin resistance. Therefore, they are not the best choice for increasing insulin sensitivity. D. Peroxisome proliferator-activated receptor gamma (PPAR-\u03b3): This is a type of nuclear receptor that plays a key role in regulating glucose and lipid metabolism. PPAR-\u03b3 agonists, such as thiazolidinediones, are known to increase insulin sensitivity by promoting glucose uptake in skeletal muscle and adipose tissue, making this the correct answer. Therefore, the endogenous signaling molecule that will increase insulin sensitivity in this patient is PPAR-\u03b3. Here is the output in json format: {\"step_by_step_thinking\": \"The patient's pre-diabetic state and obesity suggest a focus on improving insulin sensitivity. The glucose tolerance test results indicate impaired glucose regulation. The correct answer is PPAR-\u03b3, as it is a key regulator of glucose and lipid metabolism and has been shown to increase insulin sensitivity.\", \"answer_choice\": \"D\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 29.0804660320282
}